Clifford Chance has advised Keymed Biosciences (Chengdu) Co., Ltd. on the deal. Keymed Biosciences (Chengdu) Co., Ltd. completed an out-licensing transaction with Belenos Biosciences, Inc.to exclusively...
Keymed Biosciences Inc.’s Out-Licensing Transaction With Belenos Biosciences
Lepu Biopharma and Keymed Biosciences’ Licensing Agreement with AstraZeneca AB
Zhong Lun advised Lepu Bio on the deal while Sidley represented Keymed Biosciences. Lepu Biopharma Co., Ltd and Keymed Biosciences Inc. signed a global exclusive license agreement...
Keymed Biosciences’ US$400 Million Hong Kong IPO
O’Melveny & Myers and Cooley LLP advised Keymed Biosciences Inc. on the deal, while Kirkland & Ellis advised the joint sponsors and underwriters. Keymed Biosciences Inc....